Nirsevimab is a monoclonal antibody that binds to the RSV fusion protein. During the Phase 2b (NCT02878330) and MELODY (NCT03979313) clinical trials, infants received one dose of nirsevimab or placebo before their first RSV season.

This article presents an overview of European Union (EU) statistics related to influenza.

The European Public Health Alliance have signed a memorandum of understanding with WHO Europe to enhance their partnership. Both organisations will work closely to address key health challenges and drive positive change.

A study assessing scientific, engineering, legal and economic considerations of flexible EU manufacturing and innovation of medical countermeasures for serious cross-border threats to health

Spillover events of avian influenza A viruses (IAVs) to humans could represent the first step in a future pandemic. Several factors that limit the transmission and replication of avian IAVs in mammals have been identified.

RSV causes a substantial burden worldwide. After over six decades of research, there is finally a licensed immunization option that can protect the broad infant population, and other will follow soon.

Data on the protection conferred by COVID-19 vaccination and previous SARS-CoV-2 infection against omicron (B.1.1.529) infection in young children are scarce.

In order to better define the need for influenza vaccination in people with diabetes (DM), we collected all available evidence on the effect of DM as a risk factor for complications of both seasonal and pandemic influenza.

Ahead of the UN High-level Meeting on Pandemic Prevention, Preparedness, and Response, taking place in September, ESWI has joined the Pandemic Action Network, alongside more than 90 partners, in signing a political declaration calling leaders for action.

The sequelae of SARS-CoV-2 infection can involve multiple organ systems and are often grouped together as “long Covid” or PASC (postacute sequelae of SARS-CoV-2)

The European Public Health Alliance's manifesto presents five key priorities, aiming at strengthening public health and securing the EU’s resilience by working on pandemic preparedness and response.

What do we know about long-Covid? In this captivating episode we listen to the personal and powerful account of how the lingering effects of Sars-CoV-2 has wreaked havoc in an otherwise healthy person.